A landmark study involving 2.5 million individuals has established a clear biological basis for fibromyalgia by identifying specific genetic risk factors.
New research suggests melatonin, typically used as a sleep aid, may offer therapeutic benefits for individuals experiencing chronic musculoskeletal pain.